Embracing Diversity & Inclusion

11. Gaining Trust, Giving Support, & Forgetting The “Perfect Patient”: Ways To Achieve Diverse Clinical Trial Recruitment 12/19/2022

    Forget the "perfect patient" and find the right patient. Pandy Opima, M.D., director study leader, Early Oncology R&D, at AstraZeneca, presents ways to truly achieve clinical trial diversity.

12. Don’t Wait On Legislation To Begin Leveraging DEI 12/16/2022

    Industry and academia alike are experiencing a greater urgency for awareness, education, understanding, and application of diversity, equity, and inclusion (DEI). This begs the question of whether people are willing to move from the comfort of “recommended” training to the potential discomfort and discord inherent in “required” training.

13. How Psychological And Cultural Safety Can Accelerate Diverse Patient Recruitment And Retention 12/12/2022

    Cultural and psychological safety is essential to achieving diversity in clinical trials. As sponsors enable their diverse teams to unleash their creativity in a psychologically and culturally safe environment, they will design protocols, consent forms, and reimbursements adapted to the needs of real-world patient populations.

14. A Firsthand Experience In Africa — Sub-Sahara Has A Lot To Offer 12/6/2022

    In “Better Than Expected — A Firsthand Experience In Africa,” Kamila Novak shared her positive impressions from visiting medical research centers in sub-Saharan Africa. However, the picture would not be complete without talking about the continent’s personal safety and professional security, regulatory landscape, and ongoing socioeconomic challenges.

15. A Firsthand Experience In Africa — Better Than Expected 11/29/2022

    Except for South Africa, sub-Saharan African countries are still largely underrepresented in the global clinical study map. Hesitation to conduct clinical studies in Africa may be partly a result of assumed poor infrastructure, missing regulations, and inexperienced researchers. But is it truly so? Or is our thinking stuck somewhere in the past?

16. 5 Trends Across Employee And Clinical Trial Recruitment 11/28/2022

    Whether in the world of employment or clinical trials recruitment, if recruits can’t find what they’re looking for from you, they will find it from someone else or fail to engage entirely. Explore five trends crucial to successful employee and trial participant recruitment.

17. LATAM’s Regulatory Framework For Medtech Early Feasibility Studies 11/11/2022

    Latin America is a compelling region to conduct medtech early feasibility studies due to its ethnically diverse population, its high rate of urbanization, and more. Here, the author spotlights Colombia, Brazil, and Mexico as the hotspots for medtech feasibility studies in Latin America. 

18. How — And Why — To Embrace Intersectionality In Clinical Trials 11/10/2022

    Intersectionality is the framework for how a person’s relationships, identities, interactions, and interdependencies can create different advantages and disadvantages. In order to fully embrace intersectionality and make meaningful impacts in clinical trial recruitment of diverse populations, the entire journey of the patient must be realized — every step of the way.

19. 5 Ways To Expand Racial & Ethnic Diversity In Clinical Trials 10/13/2022

    Between 2000 and 2020, nearly 80% of clinical trial participants were white. The underrepresentation of diverse racial and ethnic groups is not new, but we must do more to address disparities. Here are five strategies for action.

20. Biomarker Testing: A Key Component To Advancing Precision Medicine 9/13/2022

    Biomarker testing isn’t always the standard of care for many people living with cancer today. Providers and patients need to be better educated about biomarker testing, we need a consistent standard of care across oncology institutions, and we need to advocate for equitable access to biomarker testing.